Nutra Pharma Corp (NPHC) Current Leases (2018 - 2025)

Nutra Pharma has disclosed Current Leases across 8 years of filings, most recently posting $24056.0 for Q3 2025.

• In Q3 2025, Current Leases fell 73.54% year-over-year to $24056.0; the TTM figure through Sep 2025 stood at $24056.0 (down 73.54% YoY), while the FY2024 annual figure was $93411.0, up 11.6% from the prior year.
• Current Leases came in at $24056.0 for Q3 2025 at Nutra Pharma, down from $47637.0 in the prior quarter.
• In the past five years, Current Leases ranged from a high of $93411.0 in Q4 2024 to a low of $20003.0 in Q3 2022.
• Average Current Leases over 5 years is $69182.5, with a median of $75632.0 recorded in 2021.
• Year-over-year, Current Leases tumbled 73.55% in 2022 and soared 307.03% in 2023.
• Over 5 years, Current Leases stood at $77673.0 in 2021, then dropped by 3.65% to $74837.0 in 2022, then gained by 11.85% to $83703.0 in 2023, then rose by 11.6% to $93411.0 in 2024, then slumped by 74.25% to $24056.0 in 2025.
• Per Business Quant data, the three most recent Current Leases figures were $24056.0 in Q3 2025, $47637.0 in Q2 2025, and $70752.0 in Q1 2025.